Prognostic Value of Proteolysis Indexes in the Formation of Diabetic Retinopathy
Journal Title: Міжнародний ендокринологічний журнал - Year 2016, Vol 3, Issue 75
Abstract
The article presents the results of the study on the violations in the proteolysis system of patients with type 2 diabetes mellitus (DM) and diabetic retinopathy (DR). We have evaluated the levels of matrix metalloproteinase‑9 (MMP‑9) and tissue inhibitor of matrix metalloproteinase‑1 (TIMP‑1) in the blood and in the aqueous humor (AH) of patients with type 2 DM by means of immunoenzyme method (Bender Medsystems, Austria). The changes in proteolysis system were detected in patients with DR and type 2 DM, they consisted in the increase in the levels of MMP‑9 and TIMP‑1 in the blood and AH in patients both with no signs of DR and with any its stage, compared to the levels of these parameters in patients without diabetes. It was found that MMP‑9 level in the AH and DM type 2 duration have an impact on the probability of developing diabetic macular edema (DME). At the level of MMP‑9 ≥ 105 ng/ml and duration of type 2 DM ≥ 10 years, the risk of developing DME is 100 %. The probability of proliferative DR in patients with type 2 DM over four years of follow-up is influenced: by the level of MMP‑9 in the AH, stage of DR at baseline and duration of DM type 2. When the level of MMP‑9 is ≥ 100 ng/ml, type 2 DM duration ≥ 10 years and there are no signs of DR at the beginning of the observation, the probability of proliferative DR is 85.9 %.
Authors and Affiliations
S. V. Ziablitsev, O. V. Korobova, V. M. Serdiuk, S. Yu. Mohylevskyi
Pathogenetic and clinical correlation of type 2 diabetes mellitus with metabolic syndrome and chronic coronary artery disease
Background. Increase of morbidity of diabetes mellitus (DM) associated with coronary artery disease (CAD) on the background of metabolic syndrome (MS) is worrisome. It is very important to improve the diagnosis of this a...
Proceedings of the research-to-practice conference with international participation “ML DILA”, 20 years of partnership”
.
In Tune with the World Trends: Clinical Aspects of Liraglutide Use in Combination with Insulin in Patients with Diabetes Mellitus (Literature Review and Clinical Observations)
There is presented a review of the literature on the treatment of diabetes mellitus type 1 and 2 based on incretin effect, the mechanisms of action, advantages and limitations of a new class of antidiabetic drugs — gluc...
The Influence of Metabolic Disorders on Clinical Manifestations of Osteoarthritis and the Method for Predicting Its Course
The objective of the research: to study the impact of metabolic syndrome parameters on the clinical signs of osteoarthritis and to develop the method for predicting osteoarthritis severity based on components of the meta...
Prevalence of Growth Hormone Deficiency in Adults with Pituitary Adenomas
In this article, the authors analyzed the data of patients with pituitary tumors, of which 35 (87.5 %) suffered from growth hormone deficiency (GHD) in adults with neuroendocrine complications. Specific to GHD is a group...